Combination of Cannabidiol and Low-Dose Buprenorphine Suggests Synergistic Analgesia and Attenuates Buprenorphine-Induced Respiratory Depression.

IF 3.1 4区 医学 Q2 PHARMACOLOGY & PHARMACY
Marisa S Briones, Dustin Z DeYoung, Keith G Heinzerling
{"title":"Combination of Cannabidiol and Low-Dose Buprenorphine Suggests Synergistic Analgesia and Attenuates Buprenorphine-Induced Respiratory Depression.","authors":"Marisa S Briones, Dustin Z DeYoung, Keith G Heinzerling","doi":"10.1089/can.2025.0004","DOIUrl":null,"url":null,"abstract":"<p><p><b>Introduction:</b> As opioid-related drug overdoses remain a public health crisis, there is a critical need for innovative approaches to developing safer analgesics with improved safety profiles. BDH-001 is a fixed-dose combination of low-dose buprenorphine (BUP) and cannabidiol (CBD) being developed as a safer analgesic than currently available opioids. The purpose of this study was to examine the analgesic and opioid-sparing effects of BDH-001 and to complete an <i>in vivo</i> safety assessment in rats. <b>Methods:</b> Analgesic effect of BDH-001 was assessed using the chronic constriction injury model of chronic neuropathic pain with pain threshold assessed <i>via</i> Von Frey testing. Drug-drug interaction effects on pharmacokinetic (PK) parameters were assessed in a single dose PK study in rodents. The effects on respiratory depression were also assessed and confirmed in two separate rodent studies performing blood gas analysis and measuring O<sub>2</sub> saturation. <b>Results:</b> BDH-001 (combination of subanalgesic BUP dose and CBD) resulted in statistically significant increases in pain threshold compared to saline (<i>p</i> < 0.001), CBD alone (<i>p</i> < 0.01), and BUP alone (<i>p</i> < 0.05). The half-life of BUP was significantly shorter in the presence of CBD compared to BUP alone (<i>p</i> = 0.008), with no significant changes in any other BUP pharmacokinetic parameter assessed. CBD was found to attenuate BUP-induced respiratory depression in rats when assessing blood gases (<i>p</i> < 0.05) and O<sub>2</sub> saturation (<i>p</i> < 0.05) over several time bins. <b>Conclusions:</b> Data obtained in the present study indicate the addition of CBD to BUP was opioid-sparing and attenuated BUP- but not morphine-induced respiratory depression. There was no evidence these findings were the result of a PK interaction. Results support the hypothesis that BDH-001, a fixed-dose combination of BUP and CBD, may provide effective analgesia with a more favorable safety profile.</p>","PeriodicalId":9386,"journal":{"name":"Cannabis and Cannabinoid Research","volume":" ","pages":""},"PeriodicalIF":3.1000,"publicationDate":"2025-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cannabis and Cannabinoid Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1089/can.2025.0004","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: As opioid-related drug overdoses remain a public health crisis, there is a critical need for innovative approaches to developing safer analgesics with improved safety profiles. BDH-001 is a fixed-dose combination of low-dose buprenorphine (BUP) and cannabidiol (CBD) being developed as a safer analgesic than currently available opioids. The purpose of this study was to examine the analgesic and opioid-sparing effects of BDH-001 and to complete an in vivo safety assessment in rats. Methods: Analgesic effect of BDH-001 was assessed using the chronic constriction injury model of chronic neuropathic pain with pain threshold assessed via Von Frey testing. Drug-drug interaction effects on pharmacokinetic (PK) parameters were assessed in a single dose PK study in rodents. The effects on respiratory depression were also assessed and confirmed in two separate rodent studies performing blood gas analysis and measuring O2 saturation. Results: BDH-001 (combination of subanalgesic BUP dose and CBD) resulted in statistically significant increases in pain threshold compared to saline (p < 0.001), CBD alone (p < 0.01), and BUP alone (p < 0.05). The half-life of BUP was significantly shorter in the presence of CBD compared to BUP alone (p = 0.008), with no significant changes in any other BUP pharmacokinetic parameter assessed. CBD was found to attenuate BUP-induced respiratory depression in rats when assessing blood gases (p < 0.05) and O2 saturation (p < 0.05) over several time bins. Conclusions: Data obtained in the present study indicate the addition of CBD to BUP was opioid-sparing and attenuated BUP- but not morphine-induced respiratory depression. There was no evidence these findings were the result of a PK interaction. Results support the hypothesis that BDH-001, a fixed-dose combination of BUP and CBD, may provide effective analgesia with a more favorable safety profile.

大麻二酚与小剂量丁丙诺啡联用可协同镇痛,减轻丁丙诺啡引起的呼吸抑制。
导论:由于阿片类药物过量仍然是一个公共卫生危机,因此迫切需要创新方法来开发更安全、安全性更高的镇痛药。BDH-001是一种低剂量丁丙诺啡(BUP)和大麻二酚(CBD)的固定剂量组合,是一种比目前可用的阿片类药物更安全的镇痛药。本研究的目的是研究BDH-001的镇痛和阿片保留作用,并完成大鼠体内安全性评估。方法:采用慢性神经性疼痛慢性收缩损伤模型,采用Von Frey法评估痛阈,评价BDH-001的镇痛作用。在啮齿类动物单剂量药代动力学研究中,评估了药物-药物相互作用对药代动力学(PK)参数的影响。对呼吸抑制的影响也进行了评估,并在两项单独的啮齿动物研究中得到证实,进行了血气分析和测量氧饱和度。结果:与生理盐水(p < 0.001)、单独使用CBD (p < 0.01)和单独使用BUP (p < 0.05)相比,BDH-001(亚镇痛BUP剂量与CBD联合使用)使疼痛阈值升高,具有统计学意义。与单独使用BUP相比,CBD存在时BUP的半衰期明显缩短(p = 0.008),其他BUP药代动力学参数均无显著变化。在数个时间周期内评估血气(p < 0.05)和氧饱和度(p < 0.05)时,发现CBD可以减轻bup诱导的大鼠呼吸抑制。结论:本研究获得的数据表明,在BUP中加入CBD可以减少阿片类药物的使用,减轻BUP,但不会引起吗啡引起的呼吸抑制。没有证据表明这些发现是PK相互作用的结果。结果支持BDH-001的假设,BDH-001是BUP和CBD的固定剂量组合,可能提供更有利的安全性的有效镇痛。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Cannabis and Cannabinoid Research
Cannabis and Cannabinoid Research PHARMACOLOGY & PHARMACY-
CiteScore
6.80
自引率
7.90%
发文量
164
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信